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Abstract-This study examined the association of blood glutathione level, a potential 
marker of physiological/functional aging, with a number of biomedical/psychological 
traits in a subgroup (N = 33) of a representative sample of community-based elderly. 
Higher glutathione levels were associated with fewer number of illnesses (p < 0.05), 
higher levels of self-rated health (p < O.Ol), lower cholesterol (p < 0.05), lower body 
mass index, and lower blood pressures. Subjects with diagnoses of arthritis, diabetes, 
or heart disease (as assessed by physicians) had at least marginally significant lower 
glutathione levels than those who were disease free. Glutathione, together with age and 
a measure of suppressed anger, accounted for 39% of the variance of an index of 
morbidity. Glutathione, by itself, accounted for 24% of the variance. To our knowledge, 
this is the first evidence of an association of higher glutathione levels with higher levels 
of physical health in a sample of community-based elderly. Further studies in large 
samples are needed to investigate glutathione as a potential overall health risk factor 
for morbidity among the elderly. 
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INTRODUCTION 
The concept of physiological or functional age 
arose out of the observations that during senes- 
cence, elderly people of the same chronological 
age manifest different levels of decline for numer- 
ous physiological parameters. Among several 
approaches to understanding physiological de- 
cline in later life, the search for a metabolite, 
easily and objectively measured, which would be 
a marker of functional age, has assumed a central 
role [l]. Recently, the tripeptide glutathione 
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(GSH) has been suggested as a prime candidate 
PI* 
Glutathione has several major physiological 
functions: (1) protecting cells against destructive 
effects of reactive oxygen intermediates and free 
radicals; (2) detoxifying external substances such 
as drugs and environmental pollutants; (3) main- 
taining red cell membrane stability; and (4) en- 
hancing immunological function through its 
effects on lymphocytes [2,3]. These widespread 
functions suggest that the level of glutathione 
may have major health effects on the molecular, 
cellular and organ levels of individuals. 
Initial work using animal models of mos- 
quito, mouse and rat, indicated that gluta- 
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thione declined with older age, and paralleled 
the survival curves [4-6]; correction of a gluta- 
thione deficiency enhanced longevity in the 
mosquito [7]. Following these observations, in- 
vestigators began to examine glutathione in 
human samples. In a convenience sample of 
clinically healthy groups, glutathione levels were 
significantly lower in old (6&79 years) when 
compared to mature (40-59 years) subjects. 
However, levels in the very old (80-99 years) 
were similar to those of the mature group. This 
curvilinear pattern suggests that this selected 
sample of very old healthy men and women may 
represent survivors with extreme longevity [8]. 
In another convenience sample of elderly white 
women, selected on the basis of good health, 
blood glutathione levels were found to be the 
highest ever observed [9]. The purpose of the 
current study is to examine glutathione, for the 
first time, in a subgroup of a random sample of 
community-based elderly with wider health 
range (from poor to excellent). The general 
hypothesis of the research is that higher gluta- 
thione levels are associated with better overall 
health. 
SUBJECTS AND METHODS 
Subjects for this pilot study were selected 
from a random sample (N = 172) of urban, 
white, independently living elderly over the age 
of 60, interviewed and medically examined in 
1984. The design for selecting the sample for this 
pilot study (N = 33) aimed to have approxi- 
mately equal numbers of individuals who rated 
their health low, medium, and high. We also 
wanted approximately equal numbers of males 
and females in two age groups: 60-69 years and 
>70 years. For those aged 6&69, respondents 
were first stratified by low, medium, and high 
self-rated health, and then by gender. Thirteen 
respondents were randomly selected from this 
group. All 20 survivors over the age of 70 were 
then included in this pilot sample. In 1986, the 
subgroup (N = 33) was reinterviewed, and 
blood samples were drawn for the glutathione 
assay. All data for this study were derived from 
questionnaires and medical examinations ad- 
ministered in 1984 and 1986 at Providence 
Hospital in Southfield, Michigan. 
Health measures 
In 1986, using a double blind method, gluta- 
thione levels were determined in fasting blood 
samples. Blood samples were collected in 
ethylenediamine tetraacetic acid-prepared 
tubes, immediately placed on crushed ice (OC), 
and then stored at WC. Samples were shipped 
in dry ice to the laboratory of Dr C. A. Lang at 
the University of Louisville for processing. Vali- 
dation of the sample processing and storage 
conditions was carried out prior to the begin- 
ning of this study and showed that glutathione 
was stable for more than 20 days in blood 
samples prepared in this manner [8]. Gluta- 
thione was analyzed by the HPLC-DEC 
method and expressed as ,ug glutathione/lO”’ 
erythrocytes. This method simultaneously 
measures reduced and oxidized glutathione, cys- 
teine and other thiols [lo]. 
All other health measures were determined in 
1984 during an extensive medical examination 
at Providence Hospital in Southfield, Michigan. 
Blood pressure was measured by the examining 
physician on the right arm, with respondent 
seated, and before other medical tests were 
performed. Cholesterol was assayed in fasting 
blood samples. Body mass index was calculated 
by dividing weight (in kg) by height (in m’). 
Based on the physician’s assessment of pres- 
ence/absence of a series of illnesses or medical 
conditions, as well as review of more objective 
tests (e.g. EKG for heart disease, blood sugar 
levels for diabetes), a simple summary measure 
of number of illnesses constituted the mobidity 
index. 
Subjects also responded to a self-rated ques- 
tion, “How would you rate your overall health 
at the present time?” A dichotomous index of 
self-perceived health divided the sample into 
those who responded “good” or “excellent” 
versus those who rated their health as “very 
poor, ” “poor,” or “fair.” Idler et al. [l l] have 
demonstrated that global self-evaluated health 
status is a significant independent predictor of 
mortality and have reviewed other studies indi- 
cating the same result. Subjects were also asked 
whether or not they smoked cigarettes or drank 
alcoholic beverages. 
Suppressed anger measure 
Suppressed anger has previously been shown 
to be related to blood pressure [ 12, 131 and to 
cardiovascular morbidity [14], and mortality 
[ 151. A measure of anger suppression modified 
from prior scales [ 13, 151 was computed as the 
mean score of three items, namely, “boiling 
inside . . ., ” “brooding . . .,” and “feeling hurt 
. . ., ” (but not showing anger), relating to a 
respondent’s characteristic reactions to anger- 
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provoking situations. Subjects who were low on 
suppressed anger had a mean score of “1” and 
those who “always” suppressed anger had a 
mean score of “4”. 
Statistical analyses 
Statistical analyses consisted of determining 
first order and partial (on age) correlations; 
analyses of covariance (using age as a covari- 
ate); and simple and multiple regression model- 
ing. Because of the pilot character of these 
analyses (we are assessing possible correlations 
between glutathione and health indicators), we 
have used a graduated declaration of signifi- 
cance: ifp < 0.10, we have labeled the finding as 
marginally significant; and if p < 0.05, we have 
labeled the finding as statistically significant. If 
p < 0.01 or p -C 0.001, further differentiation of 
this level of statistical significance is noted. 
RESULTS 
We first examined (Table 1) the relationship 
of a number of morbidity measures to gluta- 
thione using simple correlations. Glutathione 
was found to be positively associated with age 
(p < 0.01) and marginally positively associated 
with alcohol status (p -C O.lO), and negatively 
associated with the morbidity index (p < 0.01) 
and body mass index (p < 0.05). Two other 
predictors of morbidity, cholesterol and systolic 
blood pressure, were negatively associated with 
glutathione, as expected, but did not reach 
significance. 
The strong positive association between age 
and glutathione suggested that age might be a 
potentially confounding influence on the re- 
Table 1. Correlations of glutathione (GSH) with measures 
of morbidity among Southfield elderly (n = 33) 
First-order Partial 
correlation correlation 
Measure coefficient? coefficient3 
Age 0.449*** n/a 
Morbidity index (sum) -0.495*** -0.559**** 
Suppressed anger 0.108 0.026 
Body mass index -0.324** - 0.226 
Cholesterol -0.158 -0.004 
Systolic blood pressure -0.206 - 0.208 
Alcohol status (no/yes) 0.300* 0.270* 
Cigarette smoking 0.090 0.120 
(no/yes) 
tcorrelation coefficients for the continuous variables are 
Pearson Rs. For alcohol status and cigarette smoking 
the correlation measures used are etas. 
SCorrelations cited are for each measure with GSH, con- 
trolling for age. 
Significance level: *p < 0.10; **p < 0.05; ***p < 0.01; 
****p < 0.001. 
lationship between glutathione and the other 
health attributes; glutathione was thus adjusted 
for age. Partial correlations, using age-adjusted 
glutathione increased the significance of the 
morbidity index (p < 0.001); however, body 
mass index was no longer significant. 
We next (Table 2) examined the relationship 
between age-adjusted glutathione levels and the 
physician’s and subjects’ ascertained health 
measures, using analysis of variance. Gluta- 
thione levels were analyzed for several of the 
individual illnesses. An illness was selected for 
separate analysis only if at least four respon- 
dents had the condition. For every illness, ex- 
cept urinary tract infections, those subjects who 
possessed the condition had a lower mean gluta- 
thione level than those without the condition. 
Two of the associations were marginally signifi- 
cant: arthritis and diabetes (p < O.lO), and a 
third, heart disease, was statistically significant 
(p < 0.05). In addition, respondents who rated 
their health as “good” or “excellent” had sig- 
nificantly (p < 0.01) higher blood levels of glu- 
tathione than did their counterparts in the “very 
poor”/“poor”/“fair” group. 
Finally (Table 3), separate regressions of indi- 
vidual variables on the morbidity index indi- 
cated significant associations for 3 of 8 variables 
(column 1): glutathione, body mass index and 
alcohol use. The r* for these variables, respect- 
ively, were 0.24, 0.11, and 0.09. The multiple 
regression model, including all the predictors 
(column 2) accounted for 39% of the variance 
in the morbidity measure and was significant 
(p = 0.003). Glutathione was the strongest of 
partial relationships (/3 = -0.64). The negative 
coefficient indicates that higher glutathione 
levels were associated with lower morbidity 
scores. Although the correlation between age 
and morbidity in the simple regression was not 
significant, the stepwise regression indicated 
that age, adjusted for all other covariates, was 
a marginally significant independent predictor 
(p < 0.10) as was the measure of suppressed 
anger. 
DISCUSSION 
This study provided evidence that gluta- 
thione, together with age, a measure of sup- 
pressed anger, and other predictors, accounted 
for 39% of the variance of an index of morbid- 
ity in a sample of independently living elderly 
adults. However, glutathione when examined by 
itself accounted by far for the largest portion of 
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Table 2. Mean glutathione (GSH) by measures of morbidity among Southfield 
elderly (a = 33) 
Unadjusted Age-adjusted 
Measure (n) Mean GSH Mean GSH F-value? 
Morbidity Index (1984) [2] 
@-I illnesses 



















Urinary tract infection 
No 
Yes 
Self-rated health (1986) 
Good, excellent 
Very poor, poor, fair 
(7) 454.8 477.3 
(26) 399.5 393.5 
(13) 446.6 448.3 
(19) 388.1 386.9 
(22) 
(11) 
(27) 430.5 430.5 
(6) 324.9 324.7 
(27) 420. I 419.9 
(6) 371.7 372.3 
(29) 422.2 421.6 
(4) 332.1 336.7 
(26) 418.9 419.4 




















tF-value cited is for the main effect in the analysis of variance, where GSH is adjusted 
for age. 
$The index equals the sum of “yes” responses (diagnosed and/or treated for) the 
following conditions: arthritis, glaucoma, asthma, emphysema, TB, high blood 
pressure, heart disease, circulatory problems, diabetes, ulcers, stomach problems, 
liver disease, kidney disease, urinary tract infection, cancer/leukemia, anemia, 
stroke, pneumonia, chronic headaches, and up to two other conditions. 
Significance level: *p -c 0.10; **p < 0.05; ***p < 0.01. 
Table 3. Multiple regression of the morbidity index on glutathione (GSH) and other 





R-Square of predictor 







Body mass index 
Cigarette smoking 
(0 = no; 1 = yes) 
Alcohol status 
(0 = non-drinker; 1 = drinker) 
Cholesterol 







0.010 - 0.042 
0.059 -0.011 
Full Model: R-Square = 0.39; 
F-value = 5.92 (p = 0.003) 
tWhen the stepwise regression model was generated, only the first three predictors 
(in the order listed) were found to be at least marginally significant. 
Significance level: *p c 0.10; **p < 0.05; ***p < 0.01; ****p < 0.001. 
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the variance (24%). To our knowledge, this is 
the first evidence of an association of higher 
glutathione with better physical health in a 
sample of community-based elderly. 
Individuals diagnosed as having at least one 
of several chronic illnesses had lower gluta- 
thione levels than those who were disease free, 
in six of the seven comparisons, and at least 
marginally significant in three of seven. Else- 
where, lower glutathione levels have been found 
in clinical studies of patients with chronic renal 
failure [16], malignant disorders [ 171, maturity 
onset diabetes [ 181, hypertension [19], and HIV 
infection [2&22]. In addition, after examining a 
series of consecutive hospital admissions, Lang 
[23] found a glutathione deficiency in 77% of 
patients with a variety of chronic diseases. 
Although in this study the relationship be- 
tween suppressed anger and morbidity is 
marginal, it is congruent with results from stud- 
ies with larger samples which relate anger- 
coping styles to hypertension [12, 131, morbidity 
[14], and mortality [15]. 
In this study, mean glutathione levels in- 
creased with age. At first glance, this appears to 
contradict the observations in animal models 
that glutathione decreased with age and paral- 
leled the survivorship curve [4, 51. However, in 
a more extensive study, Lang [8] found a curvi- 
linear relationship between glutathione and age 
in humans; an increase of glutathione deficient 
individuals with increasing age across six 
decades of the adult life span was observed, but 
in the oldest group @O--99 years), there were 
fewer deficient individuals (24%) than in the 
6&79 year old group (46%). Lang suggests that 
these very old were “survivors,” and that those 
with glutathione deficient levels may have died 
off. This may also be true in the present study 
of elderly. It would be important to examine 
glutathione in subsamples of elderly residing in 
nursing homes within a larger representative 
sample. 
Presently, it is unclear how glutathione exerts 
its action on the body in the presence of a 
disease state. It is possible that normal gluta- 
thione stores of overweight individuals may 
become depleted while fighting the toxic prod- 
ucts of lipid peroxidation. Consequently, when 
challenged by precursors of chronic diseases, the 
body may not have adequate reserves to combat 
a variety of noxious stimuli, resulting in the 
onset of disease. Glutathione can also neutralize 
the toxic products of medications, further de- 
pleting its stores and compromising the ability 
of the individual to fight attacks by other dis- 
eases or environmental pollutants. 
Recent research has also indicated that gluta- 
thione supplements may attenuate or reverse 
certain pathophysiological states. Glutathione 
has been used to treat idiopathic pulmonary 
fibrosis [24], hepatocellular carcinoma [25], and 
low sperm count [26] with some positive results. 
Finally, under experimental conditions, correc- 
tion of glutathione deficiency in aging 
mosquitos increased longevity 40% [7]. The 
evidence from small clinical studies that low 
levels of glutathione are associated with a num- 
ber of morbid states is rapidly accumulating. 
Inasmuch as the glutathione measure is inexpen- 
sively and reliably assessed, testing it as a poss- 
ible clinical indicator of future morbidity or 
immunodeficiency in diverse samples is worth- 
while. 
One limitation of the present study is the 2 
year hiatus between the physical examination 
and the glutathione assays. However, in a study 
with a 1 year follow-up, glutathione levels re- 
mained stable for the majority of the study 
participants [9]. Though the procedures for se- 
lecting this subsample were random, one must 
be cautious about findings from any small-num- 
bered sample. A clearer understanding of the 
nature and extent of glutathione’s role in the 
aging process awaits further investigation. Both 
longitudinal studies of large representative 
samples as well as well-designed experimental 
studies will be required. 
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